ProCE Banner Activity

我对体重增加与抗逆转录病毒疗法相关的代谢影响的最新数据的看法

Conference Coverage
Clinical Thought
体重增加与某些抗逆转录病毒疗法有关,新数据表明这可能导致代谢并发症。这些新数据将如何影响我们治疗和监测人类免疫缺陷病毒患者的方式?这是我的看法。

Released: May 01, 2020

Expiration: April 30, 2021

Share

Faculty

Princy N. Kumar

Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

Provided by

Provided by University of South Florida
ProCE Banner

Supporters

这项活动得到了Gilead Sciences;Merck & Co., Inc. 和 ViiV Healthcare 教育资金的支持。

Gilead

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

Princy N. Kumar, MD, FIDSA, MACP,透露她曾在 Amgen、Gilead Sciences、GlaxoSmithKline、Merck 和 Theratechnologies 的顾问委员会/小组或发言人局任职;已获得 Gilead Sciences、GlaxoSmithKline 和 Merck 的资助或研究支持;并拥有 Gilead Sciences、GlaxoSmithKline、Merck、Pfizer 和 Johnson & Johnson 的所有者权益。